Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Return on Assets: 2011-2018

Historic Return on Assets for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Sep 2018 value amounting to -0.43%.

  • EyePoint Pharmaceuticals' Return on Assets rose 65.00% to -0.43% in Q3 2018 from the same period last year, while for Sep 2018 it was -0.43%, marking a year-over-year increase of 65.00%. This contributed to the annual value of -1.18% for FY2018, which is 44.00% down from last year.
  • As of Q3 2018, EyePoint Pharmaceuticals' Return on Assets stood at -0.43%, which was down 0.05% from -0.43% recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Return on Assets ranged from a high of 0.33% in Q3 2014 and a low of -1.68% during Q4 2017.
  • For the 3-year period, EyePoint Pharmaceuticals' Return on Assets averaged around -0.84%, with its median value being -0.84% (2016).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Return on Assets skyrocketed by 100bps in 2014 and then crashed by 97bps in 2015.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Return on Assets stood at 0.25% in 2014, then slumped by 97bps to -0.72% in 2015, then decreased by 11bps to -0.84% in 2016, then crashed by 84bps to -1.68% in 2017, then soared by 65bps to -0.43% in 2018.
  • Its Return on Assets was -0.43% in Q3 2018, compared to -0.43% in Q2 2018 and -0.70% in Q1 2018.